Huang, Rong
Huang, Yuankai
Liu, Jiayuan
Chen, Lei
Article History
Received: 28 February 2023
Accepted: 14 September 2023
First Online: 6 October 2023
Declarations
:
: The ethical approval to conduct the pilot survey, pre-test and main survey was granted by the Ethics Committee of China Pharmaceutical University (Project Number: CPU2019015). We obtained written informed consent from the all participants. We also confirm that all methods were performed by the relevant guidelines and regulations or the Declaration of Helsinki.
: NA.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.